NCT03526679 2025-12-05LEADERNational Taiwan University HospitalPhase 1/2 Completed30 enrolled 9 charts
NCT03074318 2022-04-29Avelumab and Trabectedin in Treating Patients With Liposarcoma or Leiomyosarcoma That is Metastatic or Cannot Be Removed by SurgeryFred Hutchinson Cancer CenterPhase 1/2 Terminated35 enrolled 21 charts
NCT00949325 2019-03-11Safety and Efficacy Study of Torisel and Liposomal Doxorubicin for Patients With Recurrent SarcomaSidney Kimmel Comprehensive Cancer Center at Johns HopkinsPhase 1/2 Completed24 enrolled 14 charts
NCT01154452 2018-08-15Vismodegib and Gamma-Secretase/Notch Signalling Pathway Inhibitor RO4929097 in Treating Patients With Advanced or Metastatic SarcomaNational Cancer Institute (NCI)Phase 1/2 Completed78 enrolled 11 charts
NCT00233948 2015-04-01Nelfinavir Mesylate in Treating Patients With Recurrent, Metastatic, or Unresectable LiposarcomaCity of Hope Medical CenterPhase 1/2 Terminated29 enrolled 7 charts